Equillium, Inc.
For the period ended Mar 31, 2026. Filed May 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 13, 2026
EQ$1.46-3.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(In thousands)
| Three Months EndedMarch 31, · Three Months EndedMarch 31, | ||||
|---|---|---|---|---|
| 2026 · 2025 | ||||
| Operating activities: | ||||
| Net loss | $(5,311) | $(8,654) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation | 24 | 33 | ||
| Stock-based compensation | 930 | 621 | ||
| Net unrealized loss (gain) on foreign currency transactions | 7 | (49) | ||
| Amortization of investments, net | - | (14) | ||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses and other current assets | (192) | 303 | ||
| Accounts payable | 434 | 381 | ||
| Accrued expenses | (257) | (786) | ||
| Right-of-use assets and lease liabilities, net | 64 | (4) | ||
| Net cash used in operating activities | (4,301) | (8,169) | ||
| Investing activities: | ||||
| Purchases of property and equipment | (3) | (4) | ||
| Maturities of short-term investments | - | 4,500 | ||
| Net cash (used in) provided by investing activities | (3) | 4,496 | ||
| Financing activities: | ||||
| Proceeds from exercise of stock options | 448 | 38 | ||
| Proceeds from a private placement of common stock and pre-funded warrants, net of issuance costs | 34,898 | 53 | ||
| Net cash provided by financing activities | 35,346 | 91 | ||
| Effect of exchange rate changes on cash and cash equivalents | 3 | (1) | ||
| Net increase (decrease) in cash and cash equivalents | 31,045 | (3,583) | ||
| Cash and cash equivalents at beginning of period | 30,277 | 18,085 | ||
| Cash and cash equivalents at end of period | $61,322 | $14,502 | ||
| Non-cash investing and financing activities: | ||||
| Private placement issuance costs in accounts payable and accrued expenses | $81 | $ | - | |
| Amounts included in accounts payable for purchases of property and equipment | $71 | $ | - | |
| Exercise of stock options issuance costs in accounts payable and accrued expenses | $1 | $ | - | |
| ATM facility issuance costs in accrued expenses | $ | - | $99 | |
| ATM facility issuance costs reclassed from other current assets | $ | - | $392 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.